103882-72-0

Basic information

• Product Name: C₆H₇N*C₃₄H₅₄O₈
• CAS NO: 103882-72-0
• Molecular Weight: 683.926
• Mol File: 103882-72-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₆H₇N*C₃₄H₅₄O₈(CAS DataBase Reference)
• NIST Chemistry Reference: C₆H₇N*C₃₄H₅₄O₈(103882-72-0)
• EPA Substance Registry System: C₆H₇N*C₃₄H₅₄O₈(103882-72-0)

Safety Data

• Hazardous Substances Data: 103882-72-0(Hazardous Substances Data)

Upstream product

• 62-53-3 aniline 
• 25999-31-9 lasalocid (X 537 A) 
• 25999-20-6 lasalocid sodium 

Relevant articles and documents

X-ray crystallographic, FT-IR and NMR studies as well as anticancer and antibacterial activity of the salt formed between ionophore antibiotic Lasalocid acid and amines

Two new complexes of the ionophore antibiotic Lasalocid acid (LAS) with phenylamine (PhA) and butylamine (BuA) were synthesized and their molecular structures were studied using single crystal X-ray diffraction and spectroscopic methods. In the solid state both amines are protonated and all NH3+ protons are hydrogen bonded to etheric, hydroxyl and carboxylic oxygen atoms of the LAS anion. In chloroform solutions the structure observed in the crystal of LAS-BuA complex is preserved and an equilibrium between the LAS-PhA complex and dissociated Lasalocid acid and phenylamine is observed. In vitro antimicrobial tests of the complexes showed a significant activity towards some strains of Gram-positive bacteria. For the first time Lasalocid acid and its complexes with amines were tested in vitro for cytotoxic activity against human cancer cell lines: A-549 (lung), MCF-7 (breast), HT-29 (colon) and mouse cancer cell line P-388 (leukemia). We found that LAS and its complexes are strong cytotoxic agents towards all tested cell lines. The cytostatic activity of the compounds studied is greater than that of cisplatin, indicating that Lasalocid and its complexes are promising candidates for new anticancer drugs.